Showing results (171-180 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|September 25, 2021
Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanomaDoreen Lau, Mary A McLean, Andrew N Priest, et al.Journal for Immunotherapy of Cancer|October 20, 2019
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune responseBridget P Keenan, Lawrence Fong, Robin K KelleyJournal for Immunotherapy of Cancer|October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumorsLi Zhu, Jessica L Narloch, Sayali Onkar, et al.Journal for Immunotherapy of Cancer|October 1, 2021
CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigensSung-Woo Lee, He Yun Choi, Gil-Woo Lee, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapyMohammed G Ghonime, Uksha Saini, Michael C Kelly, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activityCongcong Zhang, Jasmin Röder, Anne Scherer, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrenceCraig L Slingluff, Karl D Lewis, Robert Andtbacka, et al.Journal for Immunotherapy of Cancer|October 5, 2021
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effectsMeggy Suarez-Carmona, Anja Williams, Jutta Schreiber, et al.Journal for Immunotherapy of Cancer|October 5, 2021
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer typesAnders Handrup Kverneland, Christopher Aled Chamberlain, Troels Holz Borch, et al.Pageof 424